International Classification of Diseases–based analysis is inaccurate in assessing the prevalence of inflammatory bowel disease in patients with hidradenitis suppurativa - 08/07/21
Funding sources: The Henry Ford Health System Department of Dermatology receives support from the Livingood Fund and Rodzik Fund, both of which funded this study and neither of which had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. |
|
Disclosure: Dr Hamzavi has served and/or currently serves as an investigator in clinical trial activities for the following companies: Abbvie, Novartis, Lenicura, Pfizer, and Incyte. Mr Gold, Dr Nicholson, and Mr Jacobsen have no conflicts of interest to disclose. |
|
Reprints not available from the authors. |
Vol 85 - N° 2
P. 495-497 - août 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?